 SEATTLE, March 08, 2022 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. NASDAQ: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in a virtual fireside chat and 1x1 meetings at Oppenheimers 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 10:40 am ET. 